Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

BHVN

Biohaven Ltd

Apr 15 • 04:00PM ET

44.77

Dollar change -8.31
Percentage change -15.66	%

Healthcare • Biotechnology • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWM VXF IWN IBB SCHA VTWO VHT DWAS LABU NUSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.67	Insider Own	14.20%	Shs Outstand	81.12M	Perf Week	-12.92%
Market Cap	3.66B	Forward P/E	-	EPS next Y	-5.88	Insider Trans	-0.09%	Shs Float	70.07M	Perf Month	-20.65%
Income	-408.17M	PEG	-	EPS next Q	-1.55	Inst Own	88.73%	Short Float	12.23%	Perf Quarter	-1.26%
Sales	0.00M	P/S	-	EPS this Y	-6.81%	Inst Trans	495.97%	Short Ratio	7.32	Perf Half Y	71.34%
Book/sh	5.28	P/B	8.49	EPS next Y	4.00%	ROA	-69.48%	Short Interest	8.57M	Perf Year	232.86%
Cash/sh	4.69	P/C	9.54	EPS next 5Y	-	ROE	-84.44%	52W Range	12.35 - 62.21	Perf YTD	4.60%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-89.60%	52W High	-28.03%	Beta	4.33
Dividend TTM	-	Quick Ratio	7.98	Sales past 5Y	0.00%	Gross Margin	-	52W Low	262.51%	ATR (14)	3.29
Dividend Ex-Date	-	Current Ratio	7.98	EPS Y/Y TTM	33.62%	Oper. Margin	0.00%	RSI (14)	32.58	Volatility	7.35% 5.67%
Employees	239	Debt/Eq	0.07	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.09	Target Price	59.22
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	38.59%	Payout	-	Rel Volume	3.00	Prev Close	53.08
Sales Surprise	-	EPS Surprise	-28.25%	Sales Q/Q	-	Earnings	Feb 29 AMC	Avg Volume	1.17M	Price	44.77
SMA20	-17.56%	SMA50	-13.94%	SMA200	30.10%	Trades		Volume	3,401,934	Change	-15.66%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-16-24	Initiated	RBC Capital Mkts	Outperform	$62
Feb-06-24	Initiated	UBS	Buy	$59
Dec-22-23	Initiated	H.C. Wainwright	Buy	$50
Dec-08-23	Initiated	Robert W. Baird	Outperform	$58
Jan-24-23	Initiated	SVB Securities	Outperform	$24
Jan-04-23	Initiated	JP Morgan	Overweight	$23
Dec-02-22	Initiated	BTIG Research	Buy	$24
Oct-26-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$158 → $27
Oct-12-22	Initiated	Piper Sandler	Overweight	$23
Aug-19-22	Downgrade	Piper Sandler	Overweight → Neutral	$149
Aug-08-22	Downgrade	Wedbush	Outperform → Neutral	$148.50
May-11-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$150
Oct-19-21	Resumed	Morgan Stanley	Equal-Weight	$107 → $145
Aug-10-21	Downgrade	UBS	Buy → Neutral	$108 → $109
Aug-03-21	Reiterated	Canaccord Genuity	Buy	$101 → $150
Mar-11-21	Initiated	UBS	Buy	$108
Dec-15-20	Initiated	H.C. Wainwright	Buy	$121
Apr-17-20	Initiated	Cowen	Outperform	$45
Feb-10-20	Downgrade	Oppenheimer	Outperform → Perform
Feb-06-20	Initiated	Mizuho	Buy

Show Previous Ratings

Apr-13-24 09:00AM	Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates (PR Newswire)
Apr-03-24 10:03PM	LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside? (TipRanks)
Feb-29-24 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments (PR Newswire)
Jan-25-24 05:31PM	Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs (InvestorPlace)
Jan-22-24 07:00AM	Obesity Drugs Lead to Muscle LossPharma Companies Want to Fix That (The Wall Street Journal) +9.24%
07:30AM	Loading…
Jan-08-24 07:30AM	Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology (PR Newswire) +10.50%
Jan-02-24 07:00AM	Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-23 03:01AM	Director Irina Antonijevic Sells 11,000 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Dec-01-23 04:30PM	Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting (PR Newswire)
Nov-16-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks)
Nov-14-23 09:15PM	Biohaven Ltd (BHVN) Reports Q3 2023 Financial Results: Advances in Clinical Programs and Strong ... (GuruFocus.com)
04:05PM	Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Nov-06-23 08:50AM	Biohaven Ltd. (BHVN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) -6.39%
Oct-31-23 09:40AM	Are Medical Stocks Lagging Biohaven Ltd. (BHVN) This Year? (Zacks)
Oct-19-23 08:50AM	Here's Why Momentum in Biohaven Ltd. (BHVN) Should Keep going (Zacks)
07:00AM	Loading…
Oct-16-23 07:00AM	Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek (PR Newswire)
Oct-06-23 01:01PM	Insider Buying: CFO Matthew Buten Acquires 22,727 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Oct-05-23 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire) +5.32%
Oct-03-23 08:50AM	Here's What Could Help Biohaven Ltd. (BHVN) Maintain Its Recent Price Strength (Zacks)
Oct-02-23 11:56PM	Biohaven Announces Pricing of $225 Million Public Offering of Common Shares (PR Newswire) -7.46%
04:36PM	BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES (PR Newswire)
Sep-29-23 10:00AM	Small Biotech Stocks Haven't Shined of Late, but I Think These 3 Could Be Stars (TheStreet.com)
10:00AM	3 Small Biotech Stocks That Could Be Stars (TheStreet.com)
Sep-28-23 07:53AM	Biohaven (BHVN) Up on Positive Data from Autoimmune Disease Drug (Zacks) +10.54%
Sep-27-23 04:09PM	Biohaven, Yet Another Rival To Argenx In Autoimmune Drugs, Just Rocketed 33% (Investor's Business Daily) +33.31%
12:25PM	Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29% (Investor's Business Daily)
12:00PM	Why Biohaven Stock Is Skyrocketing Today (Motley Fool)
Sep-14-23 07:00AM	Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy (PR Newswire)
Sep-05-23 07:00AM	Biohaven Announces Positive Data from its Exploratory Electroencephalogram (EEG) Biomarker Study of BHV-7000, Completion of Once-Daily Formulation Development, and Plan to Initiate Phase 3 Pivotal Studies (PR Newswire) -6.18%
Aug-09-23 06:01AM	Independent Director of Biohaven Picks Up 1.8% More Stock (Simply Wall St.)
09:31AM	Loading…
Jul-31-23 09:31AM	Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug Designation for Spinal Muscular Atrophy (PR Newswire)
06:59AM	Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Jul-27-23 12:50PM	Why Biohaven Stock Is Crashing Today (Motley Fool) -22.61%
07:00AM	Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates (PR Newswire)
Jun-27-23 05:31AM	2 Growth Stocks With Major Incoming Catalysts (Motley Fool)
Jun-02-23 09:11AM	Why Biohaven Stock Caught Fire This Week (Motley Fool)
Jun-01-23 04:08PM	Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High (Investor's Business Daily) +18.39%
01:01PM	How Biohaven Is Coming 'Out Of Stealth Mode' And Bullishly Extending A 4-Day Run (Investor's Business Daily)
11:29AM	Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates (Zacks)
May-31-23 07:00AM	Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day (PR Newswire) +7.56%
May-25-23 05:00PM	Biohaven to Present R&D Day at Yale School of Management (PR Newswire)
May-24-23 01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com) -5.34%
May-12-23 04:30PM	Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments (PR Newswire)
May-05-23 10:43AM	Is Biohaven (NYSE:BHVN) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Apr-17-23 07:00AM	Biohaven Expands Executive Leadership Team with Appointment of Nick Kozauer M.D. as Senior Vice President for Clinical Development and Regulatory Strategy (PR Newswire) +9.01%
Mar-30-23 09:40AM	Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-25-23 09:22AM	Bullish Biohaven Ltd. (NYSE:BHVN) insiders filled their treasuries with US$37m worth of stock over last year (Simply Wall St.)
Mar-23-23 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
11:09AM	Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders (Zacks)
Mar-22-23 07:30AM	Biohaven Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders (PR Newswire) -5.89%
Mar-14-23 07:30AM	Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting (PR Newswire)
Mar-13-23 11:39AM	Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret (Zacks) +7.48%
Feb-23-23 08:36AM	Why Earnings Season Could Be Great for Biohaven (BHVN) (Zacks)
Feb-21-23 07:30AM	Biohaven's Taldefgrobep Alfa Receives FDA Fast Track Designation for Spinal Muscular Atrophy (PR Newswire) -7.69%
Feb-10-23 02:55PM	JPMorgans Best Performing 15 Stock Picks for 2023 (Insider Monkey)
Feb-02-23 12:52PM	Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric (Investor's Business Daily)
Jan-06-23 07:58AM	J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher This Is What Makes Them Attractive Buys (TipRanks)
07:30AM	Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-05-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks) -5.94%
Dec-23-22 06:21AM	Biohaven Ltd.'s (NYSE:BHVN) market cap dropped US$151m last week; individual investors who hold 55% were hit as were institutions (Simply Wall St.) +6.44%
Nov-29-22 09:35AM	After Plunging 13% in 4 Weeks, Here's Why the Trend Might Reverse for Biohaven Ltd. (BHVN) (Zacks) +6.87%
Nov-28-22 09:55AM	How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54% (Zacks) -9.09%
Nov-21-22 09:33AM	George Soros Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
Nov-09-22 08:35AM	Biohaven Ltd. (BHVN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.33%
07:00AM	Biohaven Ltd. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
Nov-08-22 11:52AM	George Soros Stock Portfolio: Top 10 Stock Picks (Insider Monkey)
Nov-06-22 11:48AM	3 Hot Insider Trades, Plus Hedge Fund Moves: Coca-Cola, Biohaven, Carl Icahn (Investing.com)
07:00AM	Call This an Off-Label Trade (TheStreet.com)
Nov-01-22 10:01AM	Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-25-22 08:21PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
04:30PM	Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University (PR Newswire)
Oct-20-22 10:30PM	Biohaven Announces Pricing of Public Offering of Common Shares (PR Newswire)
Oct-18-22 04:12PM	Biohaven Announces Launch of Public Offering of Common Shares (PR Newswire)
Oct-07-22 03:24AM	Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Oct-06-22 10:54AM	Biohaven (BHVN) Stock Up on Spin-Off Transaction Finalization (Zacks) +7.59%
Oct-05-22 04:45PM	Why Biohaven Stock Skyrocketed Again Today (Motley Fool) +47.59%
Oct-04-22 12:29PM	Why Biohaven Stock Is Soaring Today (Motley Fool) +18.57%
07:30AM	Biohaven Sets New Course with $258 Million in Cash, a Proven Team and Deep Pipeline to Continue its Journey to Advance Science for Patients (PR Newswire)
Oct-03-22 01:01PM	Pfizer Completes Acquisition of Biohaven Pharmaceuticals (Business Wire) +11.11%
Sep-30-22 04:09PM	Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug (Investor's Business Daily) -6.80%
01:04PM	Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both Endpoints (Zacks)
Sep-29-22 04:09PM	Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test (Investor's Business Daily) -11.05%
12:24PM	Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months (Benzinga)
08:39AM	UPDATE 1-Biohaven's ALS drug fails to meet study goals (Reuters)
08:00AM	Biohaven Provides Update From Pivotal Phase 2/3 Trial with Verdiperstat in Amyotrophic Lateral Sclerosis (Healy ALS Platform Trial) (PR Newswire)
Sep-23-22 09:36AM	10 Best Blue Chip Stocks to Buy According to Phill Gross and Robert Atchinsons Adage Capital (Insider Monkey)
Sep-18-22 07:42PM	Biohaven Announces Record Date for Anticipated Spin-Off (PR Newswire)
Sep-07-22 11:30AM	Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 9.8% Since Last Earnings Report? (Zacks)
Aug-31-22 03:25PM	Hedge Funds Continue to Load Up on These 10 Growth Stocks Despite Recession Fears (Insider Monkey)
07:00AM	Real-World Administrative Claims Analysis Demonstrates That Almost Half of Migraine Patients Discontinue Barbiturate Use After Initiation of Nurtec ODT (PR Newswire)
Aug-30-22 06:20AM	Should iShares Morningstar SmallCap ETF (ISCB) Be on Your Investing Radar? (Zacks)
Aug-09-22 04:46PM	Get ready for more merger mania in the pharma sector for the rest of the year (MarketWatch)
Aug-08-22 12:39PM	Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales Beat (Zacks)
Aug-05-22 08:15AM	Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
Aug-04-22 08:45AM	Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-03-22 08:18PM	ClearBridge Investments Trimmed its Position in Biohaven Pharmaceutical (BHVN) (Insider Monkey)
07:02AM	Doximity (DOCS) to Report Q1 Earnings: What's in the Offing? (Zacks)
Jul-28-22 07:30AM	American Migraine Foundation Survey Shows Nearly All People with Migraine and Healthcare Professionals Believe Migraine and Mental Health Significantly Impact Each Other (PR Newswire)
Jul-18-22 11:20AM	AbbVie (ABBV) Seeks EU Nod for Atogepant to Prevent Migraine (Zacks)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Antonijevic Irina	Director	Dec 29 '23	Option Exercise	0.00	11,000	0	13,535	Dec 29 06:25 PM
Antonijevic Irina	Director	Dec 29 '23	Sale	41.79	11,000	459,662	2,535	Dec 29 06:25 PM
CHILDS JOHN W	Director	Oct 05 '23	Buy	22.00	454,545	9,999,990	3,998,952	Oct 10 07:07 PM
Coric Vlad	Chief Executive Officer	Oct 05 '23	Buy	22.00	340,908	7,499,976	833,120	Oct 10 07:17 AM
Coric Vlad	Chief Executive Officer	Oct 05 '23	Buy	22.00	113,637	2,500,014	1,657,031	Oct 10 07:17 AM
Buten Matthew	Chief Financial Officer	Oct 05 '23	Buy	22.00	22,727	499,994	189,380	Oct 06 07:38 AM
Bailey Gregory	Director	Oct 04 '23	Buy	22.57	17,817	402,094	1,525,788	Oct 06 07:37 AM
CHILDS JOHN W	Director	Aug 30 '23	Buy	18.44	50,000	922,180	1,975,118	Aug 31 08:56 AM
CHILDS JOHN W	Director	Aug 04 '23	Buy	19.78	100,000	1,978,430	1,925,118	Aug 07 07:29 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BHVN

Biohaven Ltd

Upgrade your FINVIZ experience